On Wednesday, Paragon 28 Inc (FNA) stock saw a modest uptick, ending the day at $10.3 which represents a slight increase of $2.80 or 37.33% from the prior close of $7.5. The stock opened at $ and ...

Analyst Michael Matson of Needham maintained a Buy rating on Paragon 28 (FNA – Research Report), with a price target of $13.00. Michael ...

Paragon 28 (FNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Turkaly ...

Paragon 28 Inc (FNA) reports record revenue growth and product innovation while addressing financial challenges and market fluctuations.

Paragon 28, Inc. (FNA) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.10 per share a year ago. These figures are ...

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

FNA is recommended for all palpable solitary or dominant nodules, independent of size. FNA is preferred over thyroid scan or ultrasonography as the initial diagnostic test for thyroid nodules.

November 29,, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA) investors of a class action representing investors that bought ...

Paragon 28 Inc (NYSE:FNA) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue ...

NEW YORK, Nov. 7, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the class ...

Paragon 28 (NYSE:FNA – Get Free Report) will be releasing its earnings data after the market closes on Tuesday, November 12th. Analysts expect Paragon 28 to post earnings of ($0.16) per share for the ...